Therefore, it is possible to assume that O. japonica can act as a p53-dependent CDK-inhibiting anticancer drug, and that its involvement in p53 activity can be a key mechanism simultaneously mediating the cell cycle and apoptosis to suppress cancer survival. The gene discussed is TP53; the disease is cancer.